Catheter-delivered drugs extend cancer patients' lives
This article was originally published in Clinica
Delivering anti-cancer drugs directly to a tumour by catheter may double the survival time of patients with colon cancer that has spread to the liver, say US radiologists. The technique, known as chemoembolisation, also involves the infusion of small particles that cut off the blood supply to the tumour, thus inhibiting its growth.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.